Dipolar fermions in a multilayer geometry

We investigate the behavior of identical dipolar fermions with aligned dipole moments in two-dimensional multilayers at zero temperature. We consider density instabilities that are driven by the attractive part of the dipolar interaction and, for the case of bilayers, we elucidate the properties of the stripe phase recently predicted to exist in this interaction regime. When the number of layers is increased, we find that this "attractive" stripe phase exists for an increasingly larger range of dipole angles, and if the interlayer distance is sufficiently small, the stripe phase eventually spans the full range of angles, including the situation where the dipole moments are aligned perpendicular to the planes. However, in this regime, we expect the behavior to be strongly modified by the binding of dipoles between layers. In the limit of an infinite number of layers, we derive an analytic expression for the mean-field interlayer effects in the density-density response function and, using this result, we find that the stripe phase is replaced by a collapse of the dipolar syste

Spontaneous patterns in coherently driven polariton microcavities

We consider a polariton microcavity resonantly driven by two external lasers which simultaneously pump both lower and upper polariton branches at normal incidence. In this setup, we study the occurrence of instabilities of the pump-only solutions towards the spontaneous formation of patterns. Their appearance is a consequence of the spontaneous symmetry breaking of translational and rotational invariance due to interaction-induced parametric scattering. We observe the evolution between diverse patterns which can be classified as single pump, where parametric scattering occurs at the same energy as one of the pumps, and as two pump, where scattering occurs at a different energy. For two-pump instabilities, stripe and checkerboard patterns become the dominant steady-state solutions because cubic parametric scattering processes are forbidden. This contrasts with the single-pump case, where hexagonal patterns are the most common arrangements. We study the possibility of controlling the evolution between different patterns. Our results are obtained within a linear stability analysis and are confirmed by finite-size full numerical calculation

Early-time dynamics of Bose gases quenched into the strongly interacting regime

We study the early-time dynamics of a degenerate Bose gas after a sudden quench of the interaction strength, starting from a weakly interacting gas. By making use of a time-dependent generalization of the Nozières-Saint-James variational formalism, we describe the crossover of the early-time dynamics from shallow to deep interaction quenches. We analyze the coherent oscillations that characterize both the density of excited states and the Tan's contact as a function of the final scattering length. For shallow quenches, the oscillatory behavior is negligible and the dynamics is universally governed by the healing length and the mean-field interaction energy. By increasing the final scattering length to intermediate values, we reveal a universal regime where the period of the coherent atom-molecule oscillations is set by the molecule binding energy. For the largest scattering lengths we can numerically simulate in the unitary regime, we find a universal scaling behavior of the typical growth time of the momentum distribution in agreement with recent experimental observations [C. Eigen et al., Nature 563, 221 (2018)10.1038/s41586-018-0674-1

Rydberg exciton-polaritons in a magnetic field

We theoretically investigate exciton-polaritons in a two-dimensional (2D) semiconductor heterostructure, where a static magnetic field is applied perpendicular to the plane. To explore the interplay between the magnetic field and strong light-matter coupling, we employ a fully microscopic theory that explicitly incorporates electrons, holes, and photons in a semiconductor microcavity. Furthermore, we exploit a mapping between the 2D harmonic oscillator and the 2D hydrogen atom that allows us to efficiently solve the problem numerically for the entire Rydberg series as well as for the ground-state exciton. In contrast to previous approaches, we can readily obtain the real-space exciton wave functions and we show how they shrink in size with the increasing magnetic field, which mirrors their increasing interaction energy and oscillator strength. We compare our theory with recent experiments on exciton-polaritons in GaAs heterostructures in an external magnetic field and we find excellent agreement with the measured polariton energies. Crucially, we are able to capture the observed light-induced changes to the exciton in the regime of very strong light-matter coupling where a perturbative coupled oscillator description breaks down. Our work can guide future experimental efforts to engineer and control Rydberg excitons and exciton-polaritons in a range of 2D material

Interaction of human hemoglobin and semi-hemoglobins with the Staphylococcus aureus hemophore IsdB: a kinetic and mechanistic insight

Among multidrug-resistant bacteria, methicillin-resistant Staphylococcus aureus is emerging as one of the most threatening pathogens. S. aureus exploits different mechanisms for its iron supply, but the preferred one is acquisition of organic iron through the expression of hemoglobin (Hb) receptors. One of these, IsdB, belonging to the Isd (Iron-Regulated Surface Determinant) system, was shown to be essential for bacterial growth and virulence. Therefore, interaction of IsdB with Hb represents a promising target for the rational design of a new class of antibacterial molecules. However, despite recent investigations, many structural and mechanistic details of complex formation and heme extraction process are still elusive. By combining site-directed mutagenesis, absorption spectroscopy, surface plasmon resonance and molecular dynamics simulations, we tackled most of the so far unanswered questions: (i) the exact complex stoichiometry, (ii) the microscopic kinetic rates of complex formation, (iii) the IsdB selectivity for binding to, and extracting heme from, α and β subunits of Hb, iv) the role of specific amino acid residues and structural regions in driving complex formation and heme transfer, and (v) the structural/dynamic effect played by the hemophore on Hb

Attributes influencing parental decision-making to receive the Tdap vaccine to reduce the risk of pertussis transmission to their newborn – outcome of a crosssectional conjoint experiment in Spain and Italy

Pertussis vaccination of parents and household contacts (‘cocooning’) to protect newborn infants is an established strategy in many countries, although uptake may be low. Many aspects may influence such decision-making. We conducted a cross-sectional survey (NCT01890447) of households and other close contacts of newborns aged ≤6 months (or of expectant mothers in their last trimester) in Spain and Italy, using an adaptive discrete-choice experiment questionnaire. Aims were to assess the relative importance of attributes influencing vaccine adoption, and to estimate variation in vaccine adoption rates and the impact of cost on vaccination rates. Six hundred and fifteen participants (Spain, n = 313; Italy, n = 302) completed the survey. Of 144 available questionnaire scenarios, the most frequently selected (14% of respondents in both countries) were infant protection by household vaccination at vaccination center, recommendation by family physician and health authorities, with information available on leaflets and websites. The attribute with highest median relative importance was ‘reduction in source of infection’ in Spain (23.1%) and ‘vaccination location’ in Italy (18.8%). Differences between other attributes were low in both countries, with media attributes showing low importance. Over 80% of respondents indicated a definite or probable response to vaccine adoption (at no-cost) with estimated probability of adoption of 89–98%; applying vaccine costs (25€ per person) would reduce the probability of uptake by 7–20% in definite/probable respondents. Awareness of these determinants is helpful in informing Health Authorities and healthcare practitioners implementing a cocooning strategy for those populations where maternal immunization is not a preferred option

MOLNUPIRAVIR COMPARED TO NIRMATRELVIR/RITONAVIR FOR COVID-19 IN HIGH-RISK PATIENTS WITH HAEMATOLOGICAL MALIGNANCY IN EUROPE. A MATCHED-PAIRED ANALYSIS FROM THE EPICOVIDEHA REGISTRY

Introduction: Molnupiravir and nirmatrelvir/ritonavir are antivirals used to prevent progression to severe SARS-CoV-2 infections, which reduce both hospitalization and mortality rates. Nirmatrelvir/ritonavir was authorised in Europe in December 2021, while molnupiravir is not yet licensed in Europe as of February 2022. Molnupiravir may be an alternative to nirmatrelvir/ritonavir, because it displays less frequent drug-drug interactions and contraindications. A caveat connected to molnupiravir derives from the mode of action inducing viral mutations. In clinical trials on patients without haematological malignancy, mortality rate reduction of molnupiravir appeared less pronounced than that of nirmatrelvir/ritonavir. Little is known about the comparative efficacy of the two drugs in patients with haematological malignancy at high-risk of severe COVID-19. Thus, we here assess the effectiveness of molnupiravir compared to nirmatrelvir/ritonavir in our cohort of patients with haematological malignancies. Methods: Clinical data of patients treated either with molnupiravir or nirmatrelvir/ritonavir monotherapy for COVID-19 were retrieved from the EPICOVIDEHA registry. Patients treated with molnupiravir were matched by sex, age (±10 years), and baseline haematological malignancy severity to controls treated with nirmatrelvir/ritonavir. Results: A total of 116 patients receiving molnupiravir for the clinical management of COVID-19 were matched to an equal number of controls receiving nirmatrelvir/ritonavir. In each of the groups, 68 (59%) patients were male; with a median age of 64 years (IQR 53-74) for molnupiravir recipients and 64 years (IQR 54-73) for nirmatrelvir/ritonavir recipients; 57% (n=66) of the patients had controlled baseline haematological malignancy, 13% (n=15) stable, and 30% (n=35) had active disease at COVID-19 onset in each of the groups. During COVID-19 infection, one third of patients from each group were admitted to hospital. Although a similar proportion of vaccinated patients was observed in both groups (molnupiravir n=77, 66% vs nirmatrelvir/ritonavir n=87, 75%), those treated with nirmatrelvir/ritonavir had more often received four doses (n=27, 23%) as compared to patients treated with molnupiravir (n=5, 4%, p<0.001). No differences were detected in COVID-19 severity (p=0.39) or hospitalization (p=1.0). No statistically significant differences were identified in overall mortality rate (p=0.78) or in survival probability (d30 p=0.19, d60 p=0.67, d90 p=0.68, last day of follow up p=0.68). In all patients, deaths were either attributed to COVID-19 or the infection contributed to death as per treating physician's judgement. Conclusions: In high-risk patients with haematological malignancies and COVID-19, molnupiravir showed rates of hospitalization and mortality comparable to those of nirmatrelvir/ritonavir in this matched-pair analysis. Molnupiravir appears to be a plausible alternative to nirmatrelvir/ritonavir for COVID-19 treatment in patients with haematological malignancy

Nirmatrelvir/ritonavir in COVID-19 patients with haematological malignancies: a report from the EPICOVIDEHA registry

Background: Nirmatrelvir/ritonavir treatment decreases the hospitalisation rate in immunocompetent patients with COVID-19, but data on efficacy in patients with haematological malignancy are scarce. Here, we describe the outcome of nirmatrelvir/ritonavir treatment in a large cohort of the latter patients. Methods: This is a retrospective cohort study from the multicentre EPICOVIDEHA registry (NCT04733729) on patients with haematological malignancy, who were diagnosed with COVID-19 between January and September 2022. Patients receiving nirmatrelvir/ritonavir were compared to those who did not. A logistic regression was run to determine factors associated with nirmatrelvir/ritonavir administration in our sample. Mortality between treatment groups was assessed with Kaplan-Meier survival plots after matching all the patients with a propensity score. Additionally, a Cox regression was modelled to detect factors associated with mortality in patients receiving nirmatrelvir/ritonavir. Findings: A total of 1859 patients were analysed, 117 (6%) were treated with nirmatrelvir/ritonavir, 1742 (94%) were treated otherwise. Of 117 patients receiving nirmatrelvir/ritonavir, 80% had received ≥1 anti-SARS-CoV-2 vaccine dose before COVID-19 onset, 13% of which received a 2nd vaccine booster. 5% were admitted to ICU. Nirmatrelvir/ritonavir treatment was associated with the presence of extrapulmonary symptoms at COVID-19 onset, for example anosmia, fever, rhinitis, or sinusitis (aOR 2.509, 95%CI 1.448-4.347) and 2nd vaccine booster (aOR 3.624, 95%CI 1.619-8.109). Chronic pulmonary disease (aOR 0.261, 95%CI 0.093-0.732) and obesity (aOR 0.105, 95%CI 0.014-0.776) were not associated with nirmatrelvir/ritonavir use. After propensity score matching, day-30 mortality rate in patients treated with nirmatrelvir/ritonavir was 2%, significantly lower than in patients with SARS-CoV-2 directed treatment other than nirmatrelvir/ritonavir (11%, p = 0.036). No factor was observed explaining the mortality difference in patients after nirmatrelvir/ritonavir administration. Interpretation: Haematological malignancy patients were more likely to receive nirmatrelvir/ritonavir when reporting extrapulmonary symptoms or 2nd vaccine booster at COVID-19 onset, as opposed to chronic pulmonary disease and obesity. The mortality rate in patients treated with nirmatrelvir/ritonavir was lower than in patients with targeted drugs other than nirmatrelvir/ritonavir. Funding: EPICOVIDEHA has received funds from Optics COMMIT (COVID-19 Unmet Medical Needs and Associated Research Extension) COVID-19 RFP program by GILEAD Science, United States (Project 2020-8223)

Age, Successive Waves, Immunization, and Mortality in Elderly COVID-19 Haematological Patients: EPICOVIDEHA Findings

Introduction: elderly patients with haematologic malignancies face the highest risk of severe COVID-19 outcomes. The infection impact in different age groups remains unstudied in detail. Methods: We analysed elderly patients (age groups: 65-70, 71-75, 76-80 and >80 years old) with hematologic malignancies included in the EPICOVIDEHA registry between January 2020 and July 2022. Univariable and multivariable Cox regression models were conducted to identify factors influencing death in COVID-19 patients with haematological malignancy. results: the study included data from 3,603 elderly patients (aged 65 or older) with haematological malignancy, with a majority being male (58.1%) and a significant proportion having comorbidities. The patients were divided into four age groups, and the analysis assessed COVID-19 outcomes, vaccination status, and other variables in relation to age and pandemic waves.tThe 90-day survival rate for patients with COVID-19 was 71.2%, with significant differences between groups. The pandemic waves had varying impacts, with the first wave affecting patients over 80 years old, the second being more severe in 65-70, and the third being the least severe in all age groups. factors contributing to 90-day mortality included age, comorbidities, lymphopenia, active malignancy, acute leukaemia, less than three vaccine doses, severe COVID-19, and using only corticosteroids as treatment. Conclusions: These data underscore the heterogeneity of elderly haematological patients, highlight the different impact of COVID waves and the pivotal importance of vaccination, and may help in planning future healthcare efforts

Spectroscopic probes of quantum many-body correlations in polariton microcavities

We theoretically investigate the many-body states of exciton polaritons that can be observed by pump-probe spectroscopy in high-Q inorganic microcavities. Here, a weak-probe "spin-down" polariton is introduced into a coherent state of "spin-up" polaritons created by a strong pump. We show that the ↓ impurities become dressed by excitations of the ↑ medium, and that they form new polaronic quasiparticles that feature two-point and three-point many-body quantum correlations that, in the low density regime, arise from coupling to the vacuum biexciton and triexciton states, respectively. In particular, we find that these correlations generate additional branches and avoided crossings in the ↓ optical transmission spectrum that have a characteristic dependence on the ↑-polariton density. Our results thus demonstrate a way to directly observe correlated many-body states in an exciton-polariton system that go beyond classical mean-field theorie